Updated  September 2016

Antimicrobial resistance is a key public health concern that threatens the management of severe clinical infections both locally and globally.

The emergence of multi-drug resistant organisms (MDRO) classified as the ESKAPE bacteria have important clinical implications for treatment.
Surveillance was conducted to determine the magnitude and pattern of resistance; data was obtained electronically from 14 public sector sentinel sites from blood samples excluding duplicates within 21 days.

These antimicrobial susceptibility data can be used to guide empiric treatment for hospital- associated infections in each facility.  Definitive therapy would then be based on the findings of laboratory results for the individual patient. Empiric antimicrobial treatment should be guided by the prevalence of resistance at the facility level.

Each hospital should pay attention to the  occurrence of these pathogens and their resistance trends and implement strict infection prevention and control measures.

Methicillin Resistant Staphylococcus aureus (MRSA)
Carbapenems resistant Enterobacteriaceae (CRE)
Multidrug resistant Acinetobacter baumannii and Pseudomonas aueruginosa (MDRO)
Please click: M&E Dashboard

*We would like acknowledge the CDW for generating the data&maps contained on this page*